Corcept: 2Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Thursday reported second-quarter profit of $20.2 million.

The Menlo Park, California-based company said it had profit of 17 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 25 cents per share.

The drug developer posted revenue of $72.3 million in the period.

Corcept expects full-year revenue in the range of $285 million to $315 million.

Corcept shares have dropped 18% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.96, a decline of 17% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CORT at https://www.zacks.com/ap/CORT